GET THE APP

Journal of Multiple Sclerosis

ISSN - 2376-0389
NLM - 101654564

Citations Report

Journal of Multiple Sclerosis : Citations & Metrics Report

Articles published in Journal of Multiple Sclerosis have been cited by esteemed scholars and scientists all around the world. Journal of Multiple Sclerosis has got h-index 11, which means every article in Journal of Multiple Sclerosis has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Multiple Sclerosis.

  2022 2021 2020 2019 2018

Year wise published articles

55 59 6 3 9

Year wise citations received

54 59 46 57 43
Journal total citations count 521
Journal Impact Factor 2.30
Journal 5 years Impact Factor 2.28
Journal CiteScore 1.96
Journal h-index 11
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal CiteScore
CiteScorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important Citations

McLaughlin PJ, Zagon IS (2015) Duration of opioid receptor blockade determines biotherapeutic response. Biochemical pharmacology 97:236-246.

Åžengül HS, Yıldızhan Åžengül SY, Forta H (2015) Genç Multipl Skleroz ve Esansiyel Tremor Hastalarında Kognitif Bozulma: KarşılaÅŸtırmalı Bir Çalışma. NÖROLOJÄ°109.

Çalışma BK (2015) Cognitive Impairment in Young Multiple Sclerosis and Essential Tremor Patients: A Comparative Study.

Patel DI, White LJ, Lira VA, Criswell DS (2016) Forced Exercise Increases Muscle Mass in EAE Despite Early Onset of Disability. Physiological Research 1: 65.

Kurna VK (2015) A Review on Traumatic Brain Injury, Diagnosis and Its Treatment. Journal of Medical and Health Sciences 24.

Wens I, Dalgas U, Verboven K, Kosten L, Stevens A (2015) Impact of high intensity exercise on muscle morphology in EAE rats. Physiological research 64: 907.

Baig AM (2015) Mitochondrial DNA Mutation in Microglia Can Be Treated by SCNT Cloning and Not by Reprogramming of Olfactory Ensheathing Cells in the Multiple Sclerosis Treatment. J Mult Scler. 2: 2376-0389.

STEWART J, BADAWI AH, KIPTOO P, SIAHAAN TJ (2015) A vaccine-like administration of PLP-PEG-B7AP and MOG-PEG-B7AP. peptides (ie, ICAM-1, LFA-1, and CD28 peptides)12: 16.

Kurna VK (2015) A Review on Traumatic Brain Injury, Diagnosis and Its Treatment. Journal of Medical and Health Sciences 24.

Hartwell BL, Martinez-Becerra FJ, Chen J, Shinogle H, Sarnowski M (2016) Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling. Biomacromolecules. 17: 710-722.

Thati S (2016) Optimizing the Treatment of Experimental Autoimmune Encephalomyelitis via Pulmonary Delivery of Soluble Antigen Arrays.

Sinha S, Crawford MP, Ortega SB, Karandikar NJ (2015) Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis. Journal of multiple sclerosis 2.

Bak TH, Chandran S, Connick P (2014) Impairment of Visual Cognition in Progressive Multiple Sclerosis. J Mult Scler 1: 129.

Laing CM, Phillips LH, Cooper CL, Hosie JA, Summers M (2015) Anger, Quality of Life and Mood in Multiple Sclerosis. J Mult Scler 2: 2.

Kurna VK (2015) A Review on Traumatic Brain Injury, Diagnosis and Its Treatment. Journal of Medical and Health Sciences 24.

Yousuf F, Kim G, Tauhid S, Glanz BI, Chu R (2016) The contribution of cortical lesions to a composite Mri scale of Disease severity in Multiple sclerosis. Frontiers in Neurology 7.

Kim G, Tauhid S, Dupuy SL, Tummala S, Khalid F, Healy BC, Bakshi R (2016) An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis. Journal of neurology 263: 531-538.

Kurna VK (2015) A Review on Traumatic Brain Injury, Diagnosis and Its Treatment. Journal of Medical and Health Sciences 24.

Etges T, Karolia K, Grint T, Taylor A, Lauder H, Daka B, Wright S (2016) an observational postmarketing safety registry of patients in the UK, germany, and switzerland who have been prescribed sativex®(ThC: CBD, nabiximols) oromucosal spray. Therapeutics and Clinical Risk Management 12: 1667.

Fazekas F, Gehring K, Gallo P, Lebrun-Frénay C, Moral E, Myhr KM (2015) Country break-out session highlights. Neurodegenerative disease management 5: 31-7.

Top